Patent · US Active

GPR84 antagonists and uses thereof

US12378229B2 · kind B2 · utility

0Cited by
108References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2022
Grant dateAug 5, 2025
Priority date
Expiry dateFeb 2, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of GPR84, and the treatment of GPR84-mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.